DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $892,080 | +45.8% | 3,717 | +53.1% | 0.19% | +44.2% |
Q1 2023 | $611,953 | -5.0% | 2,428 | 0.0% | 0.13% | -9.2% |
Q4 2022 | $644,440 | +2.8% | 2,428 | 0.0% | 0.14% | -3.4% |
Q3 2022 | $627,000 | +1.8% | 2,428 | 0.0% | 0.15% | +18.5% |
Q2 2022 | $616,000 | -13.5% | 2,428 | 0.0% | 0.12% | +4.2% |
Q1 2022 | $712,000 | -10.9% | 2,428 | 0.0% | 0.12% | -5.6% |
Q4 2021 | $799,000 | +8.1% | 2,428 | 0.0% | 0.13% | +17.8% |
Q3 2021 | $739,000 | +13.3% | 2,428 | 0.0% | 0.11% | +20.2% |
Q2 2021 | $652,000 | +19.4% | 2,428 | 0.0% | 0.09% | +9.9% |
Q1 2021 | $546,000 | -41.0% | 2,428 | -41.7% | 0.08% | -44.1% |
Q4 2020 | $926,000 | +0.2% | 4,167 | -2.9% | 0.14% | -15.2% |
Q3 2020 | $924,000 | +21.7% | 4,292 | 0.0% | 0.17% | +14.0% |
Q2 2020 | $759,000 | +27.8% | 4,292 | 0.0% | 0.15% | +13.6% |
Q1 2020 | $594,000 | -13.8% | 4,292 | -4.5% | 0.13% | +14.8% |
Q4 2019 | $689,000 | +0.1% | 4,492 | -5.7% | 0.12% | -8.0% |
Q3 2019 | $688,000 | +0.7% | 4,766 | -0.3% | 0.12% | +4.2% |
Q2 2019 | $683,000 | +8.2% | 4,780 | 0.0% | 0.12% | +5.3% |
Q1 2019 | $631,000 | +28.0% | 4,780 | 0.0% | 0.11% | +16.3% |
Q4 2018 | $493,000 | -5.0% | 4,780 | 0.0% | 0.10% | +14.0% |
Q3 2018 | $519,000 | +10.0% | 4,780 | 0.0% | 0.09% | +10.3% |
Q2 2018 | $472,000 | +0.9% | 4,780 | 0.0% | 0.08% | +1.3% |
Q1 2018 | $468,000 | +4.5% | 4,780 | -1.0% | 0.08% | +4.1% |
Q4 2017 | $448,000 | +8.2% | 4,830 | 0.0% | 0.07% | +2.8% |
Q3 2017 | $414,000 | +1.5% | 4,830 | 0.0% | 0.07% | +2.9% |
Q2 2017 | $408,000 | -1.2% | 4,830 | 0.0% | 0.07% | +16.7% |
Q1 2017 | $413,000 | +9.8% | 4,830 | 0.0% | 0.06% | +7.1% |
Q4 2016 | $376,000 | +3.6% | 4,830 | +4.3% | 0.06% | +7.7% |
Q3 2016 | $363,000 | – | 4,630 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |